Skip to main content

Do Desirable Vitamin D Levels Vary Globally?

  • Chapter
  • First Online:
Nutritional Influences on Bone Health

Abstract

Vitamin D insufficiency is a common problem worldwide, with a varying prevalence depending on the population of interest and cutoff used to define insufficiency. The medical literature has witnessed an explosion in the number of vitamin D publications over the last three decades, most convincingly supporting a beneficial effect of vitamin D on musculoskeletal parameters. This led the Institute of Medicine (IOM) to issue an update in 2011 with an increase in the recommended vitamin D intake across all age groups and to set the desirable level at 50 nmol/L. This compares modestly to the desirable level recommended by the Endocrine Society (ES) of 75 nmol/L, which is similar to that recommended by the International Osteoporosis Foundation for older individuals. While the IOM Committee focused on the population needs in North America, the Endocrine Society tried to target high-risk populations. Some of the lowest vitamin D levels are recorded in black subjects and in non-western populations, populations in whom data on fractures and falls are scarce. Information using surrogate markers for the beneficial effect of vitamin D action on musculoskeletal health has many limitations, even in Caucasian subjects where it is the most available. The calcium–vitamin D economy in blacks seems different, and the desirable vitamin D level to optimize musculoskeletal health may be lower than that of Caucasians. Furthermore, some evidence from association studies suggests an increase in the risk of fractures in blacks, and possibly Asians, at 25(OH)D levels exceeding the desirable level for Caucasians. In view of this apparent divergence, the lack of solid outcome data in other ethnic and racial groups, and the multitude of modulators that affect vitamin D metabolism and action, the notion of a global desirable vitamin D level to date is not tenable.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

1.25(OH)2 D:

1,25-Dihydroxyvitamin D

25(OH)D:

Hydroxyvitamin D

AIDS:

Acquired immune deficiency syndrome

BMI:

Body mass index

CI:

Confidence interval

ER:

Estrogen receptor

ES:

Endocrine Society

HIV:

Human Immunodeficiency virus

HR:

Hazard risk

IOF:

International Osteoporosis ­Foundation

IOM:

Institute of Medicine

LASA:

Longitudinal Aging Study Amsterdam

NHANES:

National Health and Nutrition Examination

OC:

Osteocalcin

OR:

Odds ratio

PM:

Postmenopausal

PTH:

Parathyroid hormone

RIA:

Radioimmunoassay

RR:

Relative risk or risk ratio

SNP:

Single-nucleotide polymorphism

T1DM:

Type 1 diabetes mellitus

T2DM:

Type 2 diabetes mellitus

TB:

Tuberculosis

USA:

United States of America

VDR:

Vitamin D receptor

WHI:

Women’s Health ­Initiative

References

  1. Holick MF. Vitamin D, deficiency. N Engl J Med. 2007;357(3):266–81.

    Article  PubMed  CAS  Google Scholar 

  2. Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med. 2011;364(3):248–54.

    Article  PubMed  CAS  Google Scholar 

  3. Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab. 2011;4:585–91.

    Article  CAS  Google Scholar 

  4. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2012;95(1):91–100.

    Article  PubMed  CAS  Google Scholar 

  5. Sempos C, Vesper H, Phinny K, Thienpont L, Coates P, VDSP. Is there a U- or J-shaped Association between 25-Hydroxyvitamin D and all-cause mortality? Results from the US Nationally Representative NHANES, Submitted 2012.

    Google Scholar 

  6. Holick MF. The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med. 2008;29(6):361–8.

    Article  PubMed  CAS  Google Scholar 

  7. Makariou S, Liberopoulos EN, Elisaf M, Challa A. Novel roles of vitamin D in disease: what is new in 2011? Eur J Intern Med. 2011;22(4):355–62.

    Article  PubMed  CAS  Google Scholar 

  8. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011;(7):CD007470.

    Google Scholar 

  9. Reddy Vanga S, Good M, Howard PA, Vacek JL. Role of vitamin D in cardiovascular health. Am J Cardiol. 2010;106:798–805.

    Article  PubMed  CAS  Google Scholar 

  10. Pilz S, Kienreich K, Tomaschitz A, Lerchbaum E, Meinitzer A, März W, et al. Vitamin D and cardiovascular disease: update and outlook. Scand J Clin Lab Invest Suppl. 2012;243:83–91.

    PubMed  Google Scholar 

  11. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr. 2011;65(9):1005–15.

    Article  PubMed  CAS  Google Scholar 

  12. El-Hajj Fuleihan G. Can the sunshine vitamin melt the fat? Metabolism. 2012;61(5):603–10.

    Article  PubMed  CAS  Google Scholar 

  13. Pozzilli P, Manfrini S, Crinò A, Picardi A, Leomanni C, Cherubini V, et al. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res. 2005;37(11):680–3.

    Article  PubMed  CAS  Google Scholar 

  14. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358(9292):1500–3.

    Article  PubMed  Google Scholar 

  15. EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia. 1999;42(1):51–4.

    Article  Google Scholar 

  16. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770–3.

    Article  PubMed  CAS  Google Scholar 

  17. Cantorna MT, Mahon BD. D-hormone and the immune system. J Rheumatol Suppl. 2005;76:11–20.

    PubMed  CAS  Google Scholar 

  18. Hewison M. Vitamin D, and immune function: autocrine, paracrine or endocrine? Scand J Clin Lab Invest Suppl. 2012;243:92–102.

    PubMed  Google Scholar 

  19. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832–8.

    Article  PubMed  CAS  Google Scholar 

  20. Mirzaei F, Michels KB, Munger K, O’Reilly E, Chitnis T, Forman MR, et al. Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann Neurol. 2011;70(1):30–40.

    Article  PubMed  CAS  Google Scholar 

  21. Faridar A, Eskandari G, Sahraian MA, Minagar A, Azimi A. Vitamin D and multiple sclerosis: a critical review and recommendations on treatment. Acta Neurol Belg. 2012;112:327–333.

    Article  PubMed  Google Scholar 

  22. Sinha A, Avery P, Turner S, Bailey S, Cheetham T. Vitamin D status in pediatric patients with cancer. Pediatr Blood Cancer. 2011;57(4):594–8.

    Article  PubMed  Google Scholar 

  23. Buttigliero C, Monagheddu C, Petroni P, Saini A, Dogliotti L, Ciccone G, et al. Prognostic role of vitamin d status and efficacy of vitamin D ­supplementation in cancer patients: a systematic review. Oncologist. 2011;16(9):1215–27.

    Article  PubMed  CAS  Google Scholar 

  24. Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol. 2011;29(28):3775–82.

    Article  PubMed  CAS  Google Scholar 

  25. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(12):827–38.

    PubMed  Google Scholar 

  26. Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol. 2010;121(1–2):297–300.

    Article  PubMed  CAS  Google Scholar 

  27. Arabi A, El Rassi R, El-Hajj Fuleihan G. Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol. 2010;6(10):550–61.

    Article  PubMed  CAS  Google Scholar 

  28. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20(11):1807–20.

    Article  PubMed  CAS  Google Scholar 

  29. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT. Vitamin D status: United States, 2001–2006. NCHS Data Brief. 2011;59:1–8.

    PubMed  Google Scholar 

  30. Ganji V, Zhang X, Tangpricha V. Serum 25-hydroxyvitamin D concentrations and prevalence ­estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data. J Nutr. 2012;142(3):498–507.

    Article  PubMed  CAS  Google Scholar 

  31. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–8.

    Article  PubMed  CAS  Google Scholar 

  32. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.

    Article  PubMed  CAS  Google Scholar 

  33. Harris SS, Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am J Clin Nutr. 1998;67:1232–6.

    PubMed  CAS  Google Scholar 

  34. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30:771–7.

    Article  PubMed  CAS  Google Scholar 

  35. Nesby-O’Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr. 2002;76:187–92.

    PubMed  Google Scholar 

  36. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005;293(18):2257–64.

    Article  PubMed  CAS  Google Scholar 

  37. Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P. Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab. 2007;92(4):1415–23.

    Article  PubMed  CAS  Google Scholar 

  38. Cranney A, Horsley T, O’Donnell S, Weiler H, Puil L, Ooi D, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007;158:1–235.

    Google Scholar 

  39. Jackson C, Gaugris S, Sen SS, Hosking D. The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis. QJM. 2007;100(4):185–92.

    Article  PubMed  CAS  Google Scholar 

  40. Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169(6):551–61.

    Article  PubMed  CAS  Google Scholar 

  41. Avenell A, Gillespie WJ, Gillespie LD, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2009;(2):CD000227.

    Google Scholar 

  42. Bergman GJ, Fan T, McFetridge JT, Sen SS. Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: a meta-analysis. Curr Med Res Opin. 2010;26(5):1193–201.

    Article  PubMed  CAS  Google Scholar 

  43. DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ. 2010;340:b5463.

    Article  Google Scholar 

  44. Lai JK, Lucas RM, Clements MS, Roddam AW, Banks E. Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies. BMC Public Health. 2010;10:331.

    Article  PubMed  CAS  Google Scholar 

  45. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367(1):40–9.

    Article  PubMed  CAS  Google Scholar 

  46. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, et al. Effect of Vitamin D on falls: a meta-analysis. JAMA. 2004;291(16):1999–2006.

    Article  PubMed  CAS  Google Scholar 

  47. Richy F, Dukas L, Schacht E. Differential effects of D-hormone analogs and native vitamin D on the risk of falls: a comparative meta-analysis. Calcif Tissue Int. 2008;82:102–7.

    Article  PubMed  CAS  Google Scholar 

  48. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692.

    Article  PubMed  CAS  Google Scholar 

  49. Gillespie LD, Robertson MC, Gillespie WJ, Lamb SE, Gates S, Cumming RG, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2009;(2):CD007146.

    Google Scholar 

  50. Cameron ID, Murray GR, Gillespie LD, Robertson MC, Hill KD, Cumming RG, et al. Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev. 2010;(1):CD005465.

    Google Scholar 

  51. Kalyani RR, Stein B, Valiyil R, Manno R, Maynard JW, Crews DC. Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis. J Am Geriatr Soc. 2010;58(7):1299–310.

    Article  PubMed  Google Scholar 

  52. Michael YL, Whitlock EP, Lin JS, Fu R, O’Connor EA, Gold R, et al. Primary care-relevant interventions to prevent falling in older adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2010;153(12):815–25.

    PubMed  Google Scholar 

  53. Murad MH, Elamin KB, Abu Elnour NO, Elamin MB, Alkatib AA, Fatourechi MM, et al. Clinical review: the effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96(10):2997–3006.

    Article  PubMed  CAS  Google Scholar 

  54. Dawson-Hughes B. What is the optimal dietary intake of vitamin D for reducing fracture risk? Calcif Tissue Int. 2012. doi:10.1007/S00223-012-9606-5.

  55. Willett AM. Vitamin D, status and its relationship with parathyroid hormone and bone mineral status in older adolescents. Proc Nutr Soc. 2005;64(2):193–203.

    Article  PubMed  CAS  Google Scholar 

  56. Sai AJ, Walters RW, Fang X, Gallagher JC. Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab. 2011;96(3):E436–46.

    Article  PubMed  CAS  Google Scholar 

  57. Gutiérrez OM, Farwell WR, Kermah D, Taylor EN. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int. 2011;22(6):1745–53.

    Article  PubMed  CAS  Google Scholar 

  58. Berger C, Greene-Finestone LS, Langsetmo L, Kreiger N, Joseph L, Kovacs CS. Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels. J Bone Miner Res. 2012;27(6):1381–9.

    Article  PubMed  CAS  Google Scholar 

  59. Bates CJ, Carter GD, Mishra GD, O’Shea D, Jones J, Prentice A. In a population study, can parathyroid hormone aid the definition of adequate vitamin D status? A study of people aged 65 years and over from the British National Diet and Nutrition Survey. Osteoporos Int. 2003;14(2):152–9.

    PubMed  CAS  Google Scholar 

  60. Lamberg-Allardt CJ, Outila TA, Kärkkainen MU, Rita HJ, Valsta LM. Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe? J Bone Miner Res. 2001;16(11):2066–73.

    Article  PubMed  CAS  Google Scholar 

  61. Vieth R, Ladak Y, Walfish PG. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab. 2003;88(1):185–91.

    Article  PubMed  CAS  Google Scholar 

  62. Arabi A, Baddoura R, El-Rassi R, El-Hajj Fuleihan G. Age but not gender modulates the relationship between PTH and vitamin D. Bone. 2010;47(2):408–12.

    Article  PubMed  CAS  Google Scholar 

  63. Saliba W, Barnett O, Rennert HS, Lavi I, Rennert G. The relationship between serum 25(OH)D and ­parathyroid hormone levels. Am J Med. 2011;124(12):1165–70.

    Article  PubMed  CAS  Google Scholar 

  64. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA. 2005;294(18):2336–41.

    Article  PubMed  CAS  Google Scholar 

  65. Harris SS, Soteriades E, Coolidge JA, Mudgal S, Dawson-Hughes B. Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab. 2000;85(11):4125–30.

    Article  PubMed  CAS  Google Scholar 

  66. Aloia JF, Feuerman M, Yeh JK. Reference range for serum parathyroid hormone. Endocr Pract. 2006;12(2):137–44.

    PubMed  Google Scholar 

  67. Weaver CM, McCabe LD, McCabe GP, Braun M, Martin BR, Dimeglio LA, et al. Vitamin D status and calcium metabolism in adolescent black and white girls on a range of controlled calcium intakes. J Clin Endocrinol Metab. 2008;93(10):3907–14.

    Article  PubMed  CAS  Google Scholar 

  68. Aloia JF, Chen DG, Chen H. The 25(OH)D/PTH threshold in black women. J Clin Endocrinol Metab. 2010;95(11):5069–73.

    Article  PubMed  CAS  Google Scholar 

  69. Gannagé-Yared MH, Chemali R, Yaacoub N, Halaby G. Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res. 2000;15(9):1856–62.

    Article  PubMed  Google Scholar 

  70. Yan L, Zhou B, Wang X, D’Ath S, Laidlaw A, Laskey MA, et al. Older people in China and the United Kingdom differ in the relationships among parathyroid hormone, vitamin D and bone mineral status. Bone. 2003;33(4):620–7.

    Article  PubMed  CAS  Google Scholar 

  71. Ono Y, Suzuki A, Kotake M, Zhang X, Nishiwaki-Yasuda K, Ishiwata Y, et al. Seasonal changes of serum 25-hydroxyvitamin D and intact parathyroid hormone levels in a normal Japanese population. J Bone Miner Metab. 2005;23(2):147–51.

    Article  PubMed  CAS  Google Scholar 

  72. Green TJ, Skeaff CM, Rockell JE, Venn BJ, Lambert A, Todd J, et al. Vitamin D status and its association with parathyroid hormone concentrations in women of child-bearing age living in Jakarta and Kuala Lumpur. Eur J Clin Nutr. 2008;62(3):373–8.

    Article  PubMed  CAS  Google Scholar 

  73. Bacon CJ, Woo J, Lau EM, Lam CW, Gamble GD, Reid IR. Effects of 25-hydroxyvitamin D level and its change on parathyroid hormone in premenopausal Chinese women. Osteoporos Int. 2010;21(11):1935–41.

    Article  PubMed  CAS  Google Scholar 

  74. Okazaki R, Sugimoto T, Kaji H, Fujii Y, Shiraki M, Inoue D, et al. Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D3 load in Japanese ­subjects. J Bone Miner Metab. 2011;29(1):103–10.

    Article  PubMed  CAS  Google Scholar 

  75. Shivane VK, Sarathi V, Bandgar T, Menon P, Shah NS. High prevalence of hypovitaminosis D in young healthy adults from the western part of India. Postgrad Med J. 2011;87(1030):514–8.

    Article  PubMed  Google Scholar 

  76. El-Hajj Fuleihan G, Nabulsi M, Choucair M, Salamoun M, Hajj Shahine C, Kizirian A, et al. Hypovitaminosis D in healthy school children. Pediatrics. 2001;107(4):E53.

    Article  PubMed  CAS  Google Scholar 

  77. Marwaha RK, Tandon N, Reddy DR, Aggarwal R, Singh R, Sawhney RC, et al. Vitamin D and bone mineral density status of healthy ­schoolchildren in northern India. Am J Clin Nutr. 2005;82(2):477–82.

    PubMed  CAS  Google Scholar 

  78. El-Hajj Fuleihan G, Nabulsi M, Tamim H, Maalouf J, Salamoun M, Khalife H, et al. Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial. J Clin Endocrinol Metab. 2006;91(2):405–12.

    Article  PubMed  CAS  Google Scholar 

  79. Ghazi AA, Hosseinpanah F, M Ardakani E, Ghazi S, Hedayati M, Azizi F. Effects of different doses of oral cholecalciferol on serum 25(OH)D, PTH, calcium and bone markers during fall and winter in schoolchildren. Eur J Clin Nutr. 2010;64(12):1415–22.

    Article  PubMed  CAS  Google Scholar 

  80. Razzaghy-Azar M, Shakiba M. Assessment of vitamin D status in healthy children and adolescents living in Tehran and its relation to iPTH, gender, weight and height. Ann Hum Biol. 2010;37(5):692–701.

    Article  PubMed  Google Scholar 

  81. Levis S, Gomez A, Jimenez C, Veras L, Ma F, Lai S, et al. Vitamin D deficiency and seasonal variation in an adult South Florida population. J Clin Endocrinol Metab. 2005;90(3):1557–62.

    Article  PubMed  CAS  Google Scholar 

  82. Hannan MT, Litman HJ, Araujo AB, McLennan CE, McLean RR, McKinlay JB, et al. Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men. J Clin Endocrinol Metab. 2008;93(1):40–6.

    Article  PubMed  CAS  Google Scholar 

  83. Heaney RP. Serum 25-hydroxyvitamin D and parathyroid hormone exhibit threshold behavior. J Endocrinol Invest. 2005;28:180–2.

    PubMed  CAS  Google Scholar 

  84. Vieth R, El-Hajj Fuleihan G. There is no lower threshold level for parathyroid hormone as 25-hydroxyvitamin D concentrations increase. J Endocrinol Invest. 2005;28:183–6.

    PubMed  CAS  Google Scholar 

  85. Durazo-Arvizu RA, Dawson-Hughes B, Sempos CT, Yetley EA, Looker AC, Cao G, et al. Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older. J Nutr. 2010;140(3):595–9.

    Article  PubMed  CAS  Google Scholar 

  86. Fleet JC, Schoch RD. Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors. Crit Rev Clin Lab Sci. 2010;47(4):181–95.

    Article  PubMed  CAS  Google Scholar 

  87. Ames SK, Ellis KJ, Gunn SK, Copeland KC, Abrams SA. Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children. J Bone Miner Res. 1999;14(5):740–6.

    Article  PubMed  CAS  Google Scholar 

  88. Zmuda JM, Cauley JA, Danielson ME, Theobald TM, Ferrell RE. Vitamin D receptor translation initiation codon polymorphism and markers of osteoporotic risk in older African-American women. Osteoporos Int. 1999;9:214–9.

    Article  PubMed  CAS  Google Scholar 

  89. Boyle IT, Gray RW, Omdahl JL, DeLuca HF, Schilling RF. The mechanism of adaptation of intestinal calcium absorption to low dietary calcium. J Lab Clin Med. 1971;78(5):813.

    PubMed  CAS  Google Scholar 

  90. Heaney RP, Barger-Lux MJ, Dowell MS, Chen TC, Holick MF. Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab. 1997;82(12):4111–6.

    Article  PubMed  CAS  Google Scholar 

  91. Heaney RP. The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol. 2005;97(1–2):13–9.

    Article  PubMed  CAS  Google Scholar 

  92. Abrams SA, Griffin IJ, Hawthorne KM, Gunn SK, Gundberg CM, Carpenter TO. Relationships among vitamin D levels, parathyroid hormone, and calcium absorption in young adolescents. J Clin Endocrinol Metab. 2005;90(10):5576–81.

    Article  PubMed  CAS  Google Scholar 

  93. Thacher TD, Abrams SA. Relationship of calcium absorption with 25(OH)D and calcium intake in children with rickets. Nutr Rev. 2010;68(11):682–8.

    Article  PubMed  Google Scholar 

  94. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr. 2003;22(2):142–6.

    PubMed  CAS  Google Scholar 

  95. Need AG, O’Loughlin PD, Morris HA, Coates PS, Horowitz M, Nordin BE. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res. 2008;23(11):1859–63.

    Article  PubMed  CAS  Google Scholar 

  96. Thacher TD, Obadofin MO, O’Brien KO, Abrams SA. The effect of vitamin D2 and vitamin D3 on intestinal calcium absorption in Nigerian children with rickets. J Clin Endocrinol Metab. 2009;94(9):3314–21.

    Article  PubMed  CAS  Google Scholar 

  97. Peng JB. TRPV5 and TRPV6 in transcellular Ca(2+) transport: regulation, gene duplication, and polymorphisms in African populations. Adv Exp Med Biol. 2011;704:239–75.

    Article  PubMed  CAS  Google Scholar 

  98. Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab. 2009;94(4):1244–50.

    Article  PubMed  CAS  Google Scholar 

  99. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med. 2004;116(9):634–9.

    Article  PubMed  CAS  Google Scholar 

  100. Cauley JA, Danielson ME, Boudreau R, Barbour KE, Horwitz MJ, Bauer DC, et al. Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the Women’s Health Initiative (WHI). J Bone Miner Res. 2011;26(10):2378–88.

    Article  PubMed  CAS  Google Scholar 

  101. Aloia JF, Talwar SA, Pollack S, Yeh J. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch Intern Med. 2005;165(14):1618–23.

    Article  PubMed  CAS  Google Scholar 

  102. Ensrud KE, Taylor BC, Paudel ML, Cauley JA, Cawthon PM, Cummings SR, et al. Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men. J Clin Endocrinol Metab. 2009;94(8):2773–80.

    Article  PubMed  CAS  Google Scholar 

  103. Garnero P, Munoz F, Sornay-Rendu E, Delmas PD. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone. 2007;40(3):716–22.

    Article  PubMed  CAS  Google Scholar 

  104. Melhus H, Snellman G, Gedeborg R, Byberg L, Berglund L, Mallmin H, et al. Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden. J Clin Endocrinol Metab. 2010;95(6):2637–45.

    Article  PubMed  CAS  Google Scholar 

  105. Islam MZ, Viljakainen HT, Kärkkäinen MU, Saarnio E, Laitinen K, Lamberg-Allardt C. Prevalence of vitamin D deficiency and secondary hyperparathyroidism during winter in pre-menopausal Bangladeshi and Somali immigrant and ethnic Finnish women: associations with forearm bone mineral density. Br J Nutr. 2012;107(2):277–83.

    Article  PubMed  CAS  Google Scholar 

  106. Scharla SH, Scheidt-Nave C, Leidig G, Woitge H, Wüster C, Seibel MJ, et al. Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study. Exp Clin Endocrinol Diabetes. 1996;104(3):289–92.

    Article  PubMed  CAS  Google Scholar 

  107. Fradinger EE, Zanchetta JR. Vitamin D and bone mineral density in ambulatory women living in Buenos Aires, Argentina. Osteoporos Int. 2001;12(1):24–7.

    Article  PubMed  CAS  Google Scholar 

  108. Harinarayan CV, Sachan A, Reddy PA, Satish KM, Prasad UV, Srivani P. Vitamin D status and bone mineral density in women of reproductive and postmenopausal age groups: a cross-sectional study from south India. J Assoc Physicians India. 2011;59:698–704.

    PubMed  CAS  Google Scholar 

  109. Khadgawat R, Brar KS, Gahlo M, Yadav CS, Malhotra R, Guptat N, et al. High prevalence of vitamin D deficiency in Asian-Indian patients with fragility hip fracture: a pilot study. J Assoc Physicians India. 2010;58:539–42.

    PubMed  Google Scholar 

  110. Arya V, Bhambri R, Godbole MM, Mithal A. Vitamin D status and its relationship with bone mineral density in healthy Asian Indians. Osteoporos Int. 2004;15(1):56–61.

    Article  PubMed  CAS  Google Scholar 

  111. Serhan E, Holland MR. Relationship of hypovitaminosis D and secondary hyperparathyroidism with bone mineral density among UK resident Indo-Asians. Ann Rheum Dis. 2002;61(5):456–8.

    Article  PubMed  CAS  Google Scholar 

  112. Hosseinpanah F, Rambod M, Hossein-nejad A, Larijani B, Azizi F. Association between vitamin D and bone mineral density in Iranian postmenopausal women. J Bone Miner Metab. 2008;26(1):86–92.

    Article  PubMed  CAS  Google Scholar 

  113. Rassouli A, Milanian I, Moslemi-Zadeh M. Determination of serum 25-hydroxyvitamin D(3) levels in early postmenopausal Iranian women: relationship with bone mineral density. Bone. 2001;29(5):428–30.

    Article  PubMed  CAS  Google Scholar 

  114. Vupputuri MR, Goswami R, Gupta N, Ray D, Tandon N, Kumar N. Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphisms in Asian Indians. Am J Clin Nutr. 2006;83(6):1411–9.

    PubMed  CAS  Google Scholar 

  115. Mitra S, Desai M, Ikram Khatkhatay M. Vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Indian women. Maturitas. 2006;55(1):27–35.

    Article  PubMed  CAS  Google Scholar 

  116. El-Hajj Fuleihan G, Dib G. The Middle East & Africa Osteoporosis Regional Audit. Epidemiology, costs, burden of osteoporosis in 2011. http://staff.aub.edu.lb/~webcmop/downloads/ME_audit.pdf. Accessed 12 Sept 2012.

  117. El-Hajj Fuleihan G, Gundberg CM, Gleason R, Brown EM, Stromski ME, Grant FD, et al. Racial differences in parathyroid hormone dynamics. J Clin Endocrinol Metab. 1994;79:1642–7.

    Article  Google Scholar 

  118. Cosman F, Morgan DC, Nieves JW, Shen V, Luckey MM, Dempster DW, et al. Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res. 1997;12:958–66.

    Article  PubMed  CAS  Google Scholar 

  119. Yan L, Schoenmakers I, Zhou B, Jarjou LM, Smith E, Nigdikar S, et al. Ethnic differences in parathyroid hormone secretion and mineral metabolism in response to oral phosphate administration. Bone. 2009;45(2):238–45.

    Article  PubMed  CAS  Google Scholar 

  120. Arabi A, Baddoura R, Awada H, Salamoun M, Ayoub G, El-Hajj Fuleihan G. Hypovitaminosis D osteopathy: is it mediated through PTH, lean mass, or is it a direct effect? Bone. 2006;39:268–75.

    Article  PubMed  CAS  Google Scholar 

  121. Arabi A, Baddoura R, El-Rassi R, El-Hajj Fuleihan G. PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly. Osteoporos Int. 2012;23(3):971–80.

    Article  PubMed  CAS  Google Scholar 

  122. Yamauchi M, Kaji H, Nawata K, Takaoka S, Yamaguchi T, Sugimoto T. Role of parathyroid hormone in bone fragility of postmenopausal women with vitamin D insufficiency. Calcif Tissue Int. 2011;88(5):362–9.

    Article  PubMed  CAS  Google Scholar 

  123. Arabi A, Mahfoud Z, Zahed L, El-Onsi L, El-Hajj Fuleihan G. Effect of age, gender and calciotropic hormones on the relationship between vitamin D receptor gene polymorphisms and bone mineral density. Eur J Clin Nutr. 2010;64(4):383–91.

    Article  PubMed  CAS  Google Scholar 

  124. Winzenberg T, Powell S, Shaw KA, Jones G. Effects of vitamin D supplementation on bone density in healthy children: systematic review and meta-analysis. BMJ. 2011;342:c7254.

    Article  PubMed  Google Scholar 

  125. Bell NH, Yergey AL, Vieira NE, Oexmann MJ, Shary JR. Demonstration of a difference in urinary calcium, not calcium absorption, in black and white adolescents. J Bone Miner Res. 1993;8:1111–5.

    Article  PubMed  CAS  Google Scholar 

  126. Bryant RJ, Wastney ME, Martin BR, Wood O, McCabe GP, Morshidi M, et al. Racial differences in bone turnover and calcium metabolism in adolescent females. J Clin Endocrinol Metab. 2003;88:1043–7.

    Article  PubMed  CAS  Google Scholar 

  127. Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, et al. IOM committee members respond to Endocrine Society guidelines. J Clin Endocrinol Metab. 2012;97:1146–52.

    Article  PubMed  CAS  Google Scholar 

  128. Narayan VKM, Ali MK, Koplan J. Global non-communicable diseases – where worlds meet. N Engl J Med. 2010;363(13):1196–8.

    Article  PubMed  CAS  Google Scholar 

  129. WHO. Global status report on non-­communicable diseases 2010 (Included as pdf: WHO_global_report). http://whqlibdoc.who.int/publications/2011/9789240686458_eng.pdf. Accessed 12 Sept 2012.

  130. Lim S, Shin H, Kim MJ, Ahn HY, Kang SM, Yoon JW, et al. Vitamin D inadequacy is associated with significant coronary artery stenosis in a community-based elderly cohort: the Korean Longitudinal Study on Health and Aging. J Clin Endocrinol Metab. 2012;97(1):169–78.

    Article  PubMed  CAS  Google Scholar 

  131. Lawn SD, Zumla AL. Tuberculosis. Lancet. 2011;378:57–72.

    Article  PubMed  Google Scholar 

  132. Martineau AR, Nhamoyebonde S, Oni T, Rangaka MX, Marais S, Bangani N, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci USA. 2011;108(47):19013–7.

    Article  PubMed  Google Scholar 

  133. Nassar N, Halligan GH, Roberts CL, Morris JM, Ashton AW. Systematic review of first-trimester vitamin D normative levels and outcomes of pregnancy. Am J Obstet Gynecol. 2011;205(3):208.e1–7.

    Article  CAS  Google Scholar 

  134. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007;92(9):3517–22.

    Article  PubMed  CAS  Google Scholar 

  135. Merewood A, Mehta SD, Chen TC, Bauchner H, Holick MF. Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab. 2009;94(3):940–5.

    Article  PubMed  CAS  Google Scholar 

  136. Powe CE, Seely EW, Rana S, Bhan I, Ecker J, Karumanchi SA, et al. First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension. 2010;56(4):758–63.

    Article  PubMed  CAS  Google Scholar 

  137. Wei SQ, Audibert F, Hidiroglou N, Sarafin K, Julien P, Wu Y, et al. Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia. BJOG. 2012;119(7):832–9.

    Article  PubMed  CAS  Google Scholar 

  138. Bodnar LM, Catov JM, Zmuda JM, Cooper ME, Parrott MS, Roberts JM, et al. Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. J Nutr. 2010;140(5):999–1006.

    Article  PubMed  CAS  Google Scholar 

  139. Leffelaar ER, Vrijkotte TG, van Eijsden M. Maternal early pregnancy vitamin D status in relation to fetal and neonatal growth: results of the multi-ethnic Amsterdam Born Children and their Development cohort. Br J Nutr. 2010;104(1):108–17.

    Article  PubMed  CAS  Google Scholar 

  140. Morley R, Carlin JB, Pasco JA, Wark JD. Maternal 25-hydroxyvitamin D and parathyroid hormone concentrations and offspring birth size. J Clin Endocrinol Metab. 2006;91(3):906–12.

    Article  PubMed  CAS  Google Scholar 

  141. Javaid MK, Crozier SR, Harvey NC, Gale CR, Dennison EM, Boucher BJ, Arden NK, et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet. 2006;367(9504):36–43.

    Article  PubMed  CAS  Google Scholar 

  142. Zamora SA, Rizzoli R, Belli DC, Slosman DO, Bonjour JP. Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls. J Clin Endocrinol Metab. 1999;84(12):4541–4.

    Article  PubMed  CAS  Google Scholar 

  143. De-Regil LM, Palacios C, Ansary A, Kulier R, Peña-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2012; 2:CD008873.

    Google Scholar 

  144. Bassir M, Laborie S, Lapillonne A, Claris O, Chappuis MC, Salle BL. Vitamin D deficiency in Iranian mothers and their neonates: a pilot study. Acta Paediatr. 2001;90(5):577–9.

    Article  PubMed  CAS  Google Scholar 

  145. Ainy E, Ghazi AA, Azizi F. Changes in calcium, 25(OH) vitamin D3 and other biochemical factors during pregnancy. J Endocrinol Invest. 2006;29(4):303–7.

    PubMed  CAS  Google Scholar 

  146. Molla AM, Al Badawi M, Hammoud MS, Molla AM, Shukkur M, Thalib L, et al. Vitamin D status of mothers and their neonates in Kuwait. Pediatr Int. 2005;47(6):649–52.

    Article  PubMed  CAS  Google Scholar 

  147. Serenius F, Elidrissy AT, Dandona P. Vitamin D nutrition in pregnant women at term and in newly born babies in Saudi Arabia. J Clin Pathol. 1984;37(4):444–7.

    Article  PubMed  CAS  Google Scholar 

  148. Kimball S, El-Hajj Fuleihan G, Vieth R. Vitamin D: a growing perspective. Crit Rev Clin Lab Sci. 2008;45(4):339–414.

    Article  PubMed  CAS  Google Scholar 

  149. Biale Y, Shany S, Levi M, Shainkin-Kestenbaum R, Berlyne GM, et al. 25 Hydroxycholecalciferol levels in Beduin women in labor and in cord blood of their infants. Am J Clin Nutr. 1979;32(12):2380–2.

    PubMed  CAS  Google Scholar 

  150. Sabour H, Hossein-Nezhad A, Maghbooli Z, Madani F, Mir E, Larijani B. Relationship between pregnancy outcomes and maternal vitamin D and calcium intake: a cross-sectional study. Gynecol Endocrinol. 2006;22(10):585–9.

    Article  PubMed  CAS  Google Scholar 

  151. Kumar GT, Sachdev HS, Chellani H, Rehman AM, Singh V, Arora H, et al. Effect of weekly vitamin D supplements on mortality, morbidity, and growth of low birthweight term infants in India up to age 6 months: randomized controlled trial. BMJ. 2011;342:d2975.

    Article  PubMed  Google Scholar 

  152. Carter GD, Carter R, Jones J, Berry J. How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin Chem. 2004;50(11):2195–7.

    Article  PubMed  CAS  Google Scholar 

  153. Binkley N, Krueger D, Cowgill CS, Plum L, Lake E, Hansen KE, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab. 2004;89(7):3152–7.

    Article  PubMed  CAS  Google Scholar 

  154. Yetley EA, Pfeiffer CM, Schleicher RL, Phinney KW, Lacher DA, Christakos S, et al. NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J Nutr. 2010;140(11):2030S–45.

    Article  PubMed  CAS  Google Scholar 

  155. Barake M, Daher RT, Salti I, Cortas NK, Al-Shaar L, Habib RH, et al. 25-hydroxyvitamin D assay variations and impact on clinical decision making. J Clin Endocrinol Metab. 2012;97(3):835–43.

    Article  PubMed  CAS  Google Scholar 

  156. Sempos CT, Vesper HW, Phinney KW, Thienpont LM, Coates PM, Vitamin D Standardization Program (VDSP). Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl. 2012;243:32–40.

    PubMed  Google Scholar 

  157. Lai JK, Lucas RM, Banks E, Ponsonby AL, Ausimmune Investigator Group. Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J. 2012;42(1):43–50.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr. Heike Bischoff-Ferrari for providing information on her debate presentation entitled “Optimal 25(OH)D level for Bone and Muscle” at the 8th Nutritional Aspects of Osteoporosis Symposium in Lausanne; Ms. Aida Farha, Medical Information Specialist, Saab Medical Library, American University of Beirut, for her advice and assistance in designing comprehensive and complex searches of the various medical literature resources and for the provision of select articles; Ms. Maha Hoteit and Mr. Ali Hammoudi for their retrieval of relevant literature; and Mr. Ali Hammoudi for the art work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ghada El-Hajj Fuleihan MD, MPH .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Fuleihan, G.EH., Rahme, M., Bassil, D. (2013). Do Desirable Vitamin D Levels Vary Globally?. In: Burckhardt, P., Dawson-Hughes, B., Weaver, C. (eds) Nutritional Influences on Bone Health. Springer, London. https://doi.org/10.1007/978-1-4471-2769-7_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2769-7_27

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2768-0

  • Online ISBN: 978-1-4471-2769-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics